Collaboration is key! A4D reaches agreement with Malaysian Endocrine & Metabolic Society
A4D has signed an agreement to work closely with healthcare professionals in Malaysia and raise awareness around Type 1 Diabetes (T1D).
Professor Dr Chan Siew Pheng, President of the Malaysian Endocrine & Metabolic Society (MEMS), put pen to paper at the end of last year on the Memorandum of Understanding (MoU) which also seeks to boost Healthcare Capacity around T1D.
The MoU is the fourth expansion agreement signed by A4D in 2021 and reflects how our HelloType1 platform is a significant new tool to educate and support the T1D Community in South-East Asia.
MEMS was formed in 1981 to advance knowledge and medical practice in endocrinology through the promotion of research and organising post-graduate teaching courses as well as organising congresses
The MOU sets our four key intentions of the Parties regarding collaboration:
To raise awareness about the burden of T1D and the consequences of this disease
To improve patient empowerment and family support for better diabetes outcomes
To strengthen healthcare capacity at both a local and regional level
To develop epidemiology data set to establish insights and clinical and quality of life measures